Mysoline (Primidone)

Primidone, the active ingredient in Mysoline, is a barbiturate anticonvulsant presented as an oral tablet for oral use. It treats partial seizures, generalized tonic‑clonic seizures and essential tremor in adults and children as prescribed.

GNH USA supplies Mysoline as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Primidone is employed to manage seizure disorders and tremor conditions.

- Partial seizures: reduces the frequency and severity of focal seizure episodes. - Generalized tonic‑clonic seizures: helps control convulsive attacks. - Essential tremor: diminishes tremor amplitude in patients with essential tremor.

Primidone may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Dizziness: sensation of light‑headedness or unsteadiness. - Ataxia: impaired coordination and balance. - Nausea: upset stomach often accompanied by an urge to vomit. - Blurred vision: temporary visual disturbances. - Fatigue: persistent lack of energy.

Serious or Rare Side Effects: - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Blood dyscrasias: including agranulocytosis or aplastic anemia. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Respiratory depression: slowed breathing, especially with other depressants. - Suicidal thoughts: emergence of depressive or suicidal ideation. - Severe rash: widespread or rapidly spreading dermatologic eruptions.

When prescribing or dispensing primidone, several safety considerations are essential.

- Dose titration: start low and increase gradually under medical supervision. - Renal impairment: adjust dose if kidney function is reduced. - Hepatic impairment: monitor liver function and consider dose modification. - Concomitant CNS depressants: use with caution due to additive sedation. - Pregnancy: risk unknown; avoid unless benefits outweigh potential hazards. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Primidone interacts with several medicines; awareness of major and moderate interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Phenobarbital: additive central nervous system depression. - Alcohol: increased sedation and risk of respiratory depression. - CYP3A4 inhibitors (e.g., erythromycin): may raise primidone plasma concentrations.

Moderate Interactions (Monitor Closely): - Carbamazepine: may lower primidone levels, reducing efficacy. - Oral contraceptives: primidone may reduce hormonal contraceptive effectiveness.